Pharma BD Deal Intelligence
Mylan Laboratories Inc. / Merck Generics (Merck KGaA)
2007 · Acquisition/Merger · $6.7B · Complete
Announcement Sentiment
75
Strongly positive
EUR 4.9B / $6.7B cash. EpiPen included. Closed Oct 2, 2007. Source: Mylan investor release, FTC, Business Standard.
Key facts
- Announced May 12, 2007
- Closed Oct 02, 2007
- Deal value $6.7B
- Deal type Acquisition/Merger
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals